Johnson Pharmacare Current Share Price | Johnson Pharmacare Stock Screener
JOHNPHARMA
Diversified Services
Johnson Pharmacare Current Stock Price Today
Live Share Price BSE
₹0.46
▲
0.00 (0.00%)
As of September 18, 2026, the live Johnson Pharmacare share price (BSE: JOHNPHARMA) is ₹0.46, unchanged from the previous close, with shares trading between ₹0.45 and ₹0.47 in today's trading session, and a 52-week range of ₹0.46–₹0.78.
Browse JOHNPHARMA cash flow statement to support your investment research.
Use the Johnson Pharmacare stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Johnson Pharmacare Market Cap
₹25.30 Cr.
JOHNPHARMA P/E Ratio (TTM)
-0.45
Johnson Pharmacare P/B Ratio
57.50
EPS (TTM)
₹-1.01
Dividend Yield
-
Debt to Equity
0.02
JOHNPHARMA 52 Week High
₹0.78
Johnson Pharmacare 52 Week Low
₹0.46
Operating Margin
-
Profit Margin
-2850.00%
JOHNPHARMA Revenue (TTM)
₹2.00
EBITDA
₹-55.00
Net Income
₹-57.00
Total Assets
₹22.00
Total Equity
-
Johnson Pharmacare Current Share Price Chart
Track the current Johnson Pharmacare share price and stock price with an interactive chart. Analyse JOHNPHARMA price trends, trading volume, historical performance, and volatility across different timeframes — the complete Johnson Pharmacare stock quote in one place.
Johnson Pharmacare Company Profile - Fundamental Screener
Screen Johnson Pharmacare company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for JOHNPHARMA shares.
Sector
Commercial Services
Industry
Diversified Services
Sub-Sector
Diversified Services
Segment
E
ISIN
INE560F01022
Johnson Pharmacare Balance Sheet Screener
Screen JOHNPHARMA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 22 | 58 | 60 | 60 | 60 | 60 | 59 | 60 | 60 | 59 |
| Current Assets | 2 | 1 | 0 | 0 | 1 | 6 | 5 | 5 | 4 | 4 |
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 21 | 1 | 2 | 2 | 1 | 1 | 1 | 2 | 2 | 1 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 0 | 56 | 57 | 57 | 58 | 58 | 58 | 58 | 58 | 58 |
| Share Capital | 55 | 55 | 55 | 55 | 55 | 50 | 50 | 50 | 50 | 50 |
| Reserves & Surplus | -55 | 1 | 2 | 2 | 3 | 8 | 8 | 8 | 8 | 8 |
Johnson Pharmacare Income Statement Screener - Profit & Revenue Analysis
Screen Johnson Pharmacare income statement and profit fundamentals.
Analyze JOHNPHARMA quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Johnson Pharmacare share price evaluation.
| Item | None-None | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2 | 0 | 0 | 0 | 3 | 3 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
| Expenses | 57 | 57 | 1 | 0 | 4 | 3 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
| EBITDA | -55 | -57 | -1 | 0 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Profit % | 0.00% | 0.00% | 0.00% | 0.00% | -53.00% | 4.00% | 0.00% | 0.00% | -1.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | -57 | -56 | -1 | 0 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | -57 | -56 | -1 | 0 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS | -1.00 | -1.01 | -0.01 | 0.00 | -0.02 | 0.00 | 0.00 | -0.02 | 0.00 | -0.01 | -0.02 | -0.03 | -0.01 |
Johnson Pharmacare Cash Flow Screener - Liquidity Fundamentals
Screen JOHNPHARMA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | -2 | 0 | 0 | 5 | 0 | 0 | -1 | -1 | 11 | -11 |
| Investing Activities | 3 | 0 | -1 | -5 | 0 | 1 | 1 | 0 | -11 | 11 |
| Financing Activities | -1 | 0 | 1 | 0 | 0 | -1 | 0 | 1 | 0 | 0 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Johnson Pharmacare Shareholding Pattern Screener
See Johnson Pharmacare shareholding pattern with promoter, FII, and DII holdings.
Check Johnson Pharmacare promoter holding and ownership changes for JOHNPHARMA on TickJournal.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 85.56% | 85.56% | 85.56% | 85.56% | 85.56% | 85.56% | 85.56% | 85.56% |
| Other Holding | 14.44% | 14.44% | 14.44% | 14.44% | 14.44% | 14.44% | 14.44% | 14.44% |
| Shareholder Count | 117,101 | 117,101 | 117,105 | 117,098 | 117,101 | 117,101 | 116,926 | 116,901 |
Johnson Pharmacare Share Dividend Screener - Share Yield Analysis
Check Johnson Pharmacare dividend history with payout and yield data.
View Johnson Pharmacare dividend details including ex-dates and amounts for JOHNPHARMA stock.
Johnson Pharmacare Stock Index Membership
See which indices include Johnson Pharmacare stock.
Check JOHNPHARMA index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Johnson Pharmacare Market Events Screener - Corporate Actions
Get Johnson Pharmacare corporate actions including splits, bonuses, and buybacks.
Check Johnson Pharmacare stock events that may affect JOHNPHARMA share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-08-13 | 2026-08-13 | Quarterly Result Announcement | NA | 2.13% |
| 2026-05-27 | 2026-05-27 | Quarterly Result Announcement | NA | -1.79% |
| 2026-02-14 | 2026-02-14 | Quarterly Result Announcement | NA | -3.28% |
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | 1.59% |
| 2025-09-25 | 2025-09-25 | Annual General Meeting | NA | -1.28% |
| 2025-07-23 | 2025-07-23 | Quarterly Result Announcement | NA | -2.27% |
| 2025-05-23 | 2025-05-23 | Quarterly Result Announcement | NA | 5.81% |
| 2025-01-31 | 2025-01-31 | Quarterly Result Announcement | NA | -1.90% |
| 2024-11-13 | 2024-11-13 | Quarterly Result Announcement | NA | 3.57% |
| 2024-09-28 | 2024-09-28 | Annual General Meeting | NA | -1.72% |
| 2022-04-07 | 2022-04-08 | Bonus | 1:10 | 30.97% |
| 2021-08-23 | 2021-08-23 | Change Of Name | NA | 0.00% |
Johnson Pharmacare Competitors Screener - Peer Comparison
Screen JOHNPHARMA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| International Gemological Institute | 13,583 | 22.10 | 1,662 | 52.68% | 711 | 31.75 |
| WeWork India Management | 9,289 | 110.42 | 2,440 | 20.56% | 53 | 43.72 |
| Nesco | 7,766 | 18.46 | 1,038 | 20.00% | 413 | 62.87 |
| Indiabulls | 6,076 | 11.74 | 833 | 166576.00% | 174 | 47.76 |
| Smartworks Coworking Spaces | 6,064 | 220.33 | 1,796 | 27.39% | 5 | 54.71 |
| SIS | 5,925 | 40.78 | 16,030 | 20.92% | 138 | 42.76 |
| Nirlon | 5,475 | 15.68 | 683 | 5.94% | 346 | 36.12 |
| Quess Corp | 5,198 | 20.92 | 15,322 | 2.21% | 222 | 51.76 |
| Indiqube Spaces | 4,301 | -46.22 | 1,528 | 38.50% | -106 | 67.50 |
| CMS Info Systems | 3,694 | 12.41 | 2,533 | 2.33% | 303 | 27.58 |
Johnson Pharmacare Company Announcements - News Screener
Screen JOHNPHARMA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-08-14 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-13 | Undertaking For Non- Applicability Of Regulation 32 Of SEBI (LODR) Regulations 2015 For The Quarter Ended On June 30Th 2026. | - |
| 2026-08-13 | Submission Of Un-Audited Financial Results Of (JOHNSON PHARMACARE LTD) For The Quarter Ended On June 30Th 2026 And Along With Limited Review Report Thereon. | - |
| 2026-08-13 | Board Meeting Outcome for Outcome Of Meeting Of Board Of Directors Held On Thursday 13Th August 2026 At Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. | - |
| 2026-08-11 | Announcement under Regulation 30 (LODR)-Change in Registered Office Address | - |
| 2026-08-08 | Board Meeting Intimation for Prior Intimation Of Board Meeting For Approval Of Un-Audited (Standalone) Financial Results For The Quarter Ended On 30Th June 2026. | - |
| 2026-07-13 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-06-26 | Closure of Trading Window | - |
| 2026-06-19 | Submission Of Audited Financials Results Of Jhonson Pharmacare Ltd. For The Quarter And Year Ended On March 31St 2026 | - |
| 2026-06-12 | Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer | - |
| 2026-06-01 | Outcome Of Meeting Of Board Of Directors Held On Wednesday 27Th May 2026 At Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. | - |
| 2026-05-30 | Compliances-Reg.24(A)-Annual Secretarial Compliance | - |
| 2026-05-28 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-05-27 | Disclosure Of Related Party Transaction Pursuant To Regulation 23(9) Of Securities And Exchange Board Of India (Listing Obligation And Disclosure Requirements) Regulations 2015. | - |
| 2026-05-27 | Undertaking For Non- Applicability Of Regulation 32 Of SEBI (LODR) Regulations 2015 For The Quarter And Financial Year Ended On March 31St 2026. | - |
| 2026-05-27 | Submission Of Audited Financial Results Of (JOHNSON PHARMACARE LTD) For The Quarter And Financial Year Ended On March 31St 2026 Along With Audited Report Thereon | - |
| 2026-05-27 | Submission Of Audited Financial Results Of (JOHNSON PHARMACARE LTD) For The Quarter And Financial Year Ended On March 31St 2026 Along With Audited Report Thereon | - |
| 2026-05-27 | Board Meeting Outcome for Outcome Of Meeting Of Board Of Directors Held On Wednesday 27Th May 2026 At Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. | - |
| 2026-05-22 | Board Meeting Intimation for Prior Intimation Of Board Meeting For Approval Of Audited Financial Results For The Quarter & Year Ended On 31St March 2026. | - |
| 2026-05-09 | Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2 | - |